Genetic separation of FK506 susceptibility and drug transport in the yeast PDr5 ATP-binding cassette multidrug resistance transporter

Molecular Biology of the Cell

Volumn 9, Issue 2, 1998, Pages 523-543

  Egner, Ralf ^a   Rosenthal, Friederike E ^a   Kralli, Anastasia ^b   Sanglard, Dominique ^c   Kuchler, Karl ^a  

^a University and Biocenter of Vienna   (Austria)

^b UNIVERSITY OF BASEL   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; ANTIFUNGAL AGENT; CYCLOHEXIMIDE; DEXAMETHASONE; DNA; ESTRADIOL; RHODAMINE; STEROID; TACROLIMUS;

AMINO ACID SUBSTITUTION; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA SEQUENCE; DRUG SENSITIVITY; DRUG TRANSPORT; ENZYME SPECIFICITY; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; PROTEIN FOLDING; SACCHAROMYCES CEREVISIAE; SITE DIRECTED MUTAGENESIS;

SACCHAROMYCES CEREVISIAE;

EID: 0031905588     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.9.2.523     Document Type: Article

References (68)

1. Al-Shawi, M.K., Urbatsch, I.L., and Senior, A.E. (1994). Covalent inhibitors of P-glycoprotein ATPase activity. J. Biol. Chem. 269, 8986-8992.
2. Azzaria, M., Schurr, E., and Gros, P. (1989). Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance. Mol. Cell. Biol. 9, 5289-5297.
3. Balzi, E., and Goffeau, A. (1994). Genetics and biochemistry of yeast multidrug resistance. Biochim. Biophys. Acta 1187, 152-162.
4. Balzi, E., Wang, M., Leterme, S., Van, D.L., and Goffeau, A. (1994). PDR5, a novel yeast multidrug resistance conferring transporter controlled by the transcription regulator PDR1. J. Biol. Chem. 269, 2206-2214.
5. Beaudet, L., and Gros, P. (1995). Functional dissection of P-glycoprotein nucleotide-binding domains in chimeric and mutant proteins. J. Biol. Chem. 270, 17159-17170.
6. Benton, B.M., Zang, J.-H., and Thorner, J. (1994). A novel FK506- and rapamycin-binding protein (FPR3 gene product) in the yeast Saccharomyces cerevisiae is a proline rotamase localized to the nucleolus. J. Cell Biol. 127, 623-639.
7. Bissinger, P.H., and Kuchler, K. (1994). Molecular cloning and ex pression of the Saccharomyces cerevisiae STS1 gene product. A yeast ABC transporter conferring mycotoxin resistance. J. Biol. Chem. 269, 4180-4186.
8. Chen, C.J., Chin, J.E., Ueda, K., Clark, D.P., Pastan, I., Gottesman, M.M., and Roninson, I.B. (1986). Internal duplication and homology with bacterial transport proteins in the MDR1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47, 381-9.
9. Cole, S.P., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, A.M., and Deeley, R.G. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258, 1650-1654.
10. Decottignies, A., and Goffeau, A. (1997). Complete inventory of the yeast ABC proteins. Nature Genet. 15, 137-145.
11. Denning, G.M., Anderson, M.P., Amara, J.F., Marshall, J., Smith, A.E., and Welsh, M.J. (1992). Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764.
12. Devine, S.E., Ling, V., and Melera, P.W. (1992). Amino acid substitutions in the 6th transmembrane domain of P-glycoprotein alter multidrug resistance. Proc. Natl. Acad. Sci. USA 89, 4564-4568.
13. Egner, R., Mahé, Y., Pandjaitan, R., Huter, V., Lamprecht, A., and Kuchler, K. (1995a). ATP binding cassette transporters in yeast: from mating to multidrug resistance. In: Membrane Protein Transport, ed. S. Rothman, Greenwich: JAI Press Inc., 57-96.
14. Egner, R., Mahé, Y., Pandjaitan, R., and Kuchler, K. (1995b). Endocytosis and vacuolar degradation of the plasma membrane localized Pdr5 ATP binding cassette multidrug transporter in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 5879-5887.
15. Eisenberg, D., Schwartz, E., Komarony, M., and Wall, R. (1984). Analysis of membrane and surface protein sequences with the hydrophobic moment plot. J. Mol. Biol. 779, 125-142.
16. Gething, M.-J., and Sambrook, J. (1992). Protein folding in the cell. Nature 355, 33-45.
17. Gottesman, M.M., Hrycyna, C.A., Schoenlein, P.V., Germann, U.A., and Pastan, I. (1995). Genetic analysis of the multidrug transporter. Annu. Rev. Genet. 29, 607-649.
18. Gros, P., Dhir, R., and Talbot, F. (1991). A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps. Proc. Natl. Acad. Sci. USA 88, 7289-93.
19. Hanna, M., Brault, M., Kwan, T., Kast, C., and Gros, P. (1996). Mutagenesis of transmembrane domain 11 of P-glycoprotein by alarvine scanning. Biochemistry 35, 3625-3635.
20. Hemenway, C.S., and Heitman, J. (1996). Immunosuppressant target protein FKBP12 is required for P-glycoprotein function in yeast. J. Biol. Chem. 272, 18527-18534.
21. Higgins, C.F. (1992). ABC transporters: from microrgansims to man. Ann. Rev. Cell Biol. 8, 67-113.
22. Hirata, D., Yano, K., Miyahara, K., and Miyakawa, T. (1994). Saccharomyces cerevisiae YDR1, which encodes a member of the ATP-binding cassette (ABC) superfamily, is required for multidrug resistance. Curr. Genet. 26, 285-294.
23. Hoof, T., Demmer, A., Hadam, M.R., Riordan, J.R., and Tummler, B. (1994). Cystic fibrosis-type mutational analysis in the ATP-binding cassette transporter signature of human P-glycoprotein MDR1. J Biol. Chem. 269, 20575-20583.
24. Iniguez-Lluhi, J.A., Lou, D.Y., and Yamamoto, K.R. (1997). Three amino acid substitutions selectively disrupt the activation but not the repression function of the glucocorticoid receptor N-terminus. J. Biol. Chem. 272, 4149-4156.
25. Jämsä, E., Simonen, M., and Makarow, M. (1994). Selective retention of secretory proteins in the yeast endoplasmic reticulum by treatment of cells with a reducing agent. Yeast 10, 355-370.
26. Jensen, T.J., Loo, M.A., Pind, S., Williams, D.B., Goldberg, A.L., and Riordan, J.R. (1995). Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 83, 129-135.
27. Kane, S.E. (1996). Multidrug resistance of cancer cells. In: Advances in Drug Research, vol. 28, eds. B. Testa and U.A. Meyer, San Diego: Academic Press, 181-252.
28. Katzmann, D.J., Hallstrom, T.C., Voet, M., Wysock, W., Golin, J., Volckaert, G., and Moye-Rowley, W.S. (1995). Expression of an ATP-binding cassette transporter-encoding gene (YOR1) is required for oligomycin resistance in Saccharomyces cerevisiae. Mol. Cell. Biol. 15, 6875-6883.
29. Kolaczkowski, M., van der Rest, M., Cybularz-Kolaczkowska, A., Soumillion, J.P., Konings, W.N., and Goffeau, A. (1996). Anticancer drugs, ionophoric peptides, and steroids as substrates of the yeast multidrug transporter Pdr5p. J. Biol. Chem. 271, 31543-31548.
30. Kralli, A., Bohen, S.P., and Yamamoto, K.R. (1995). LEM1, an ATP-binding cassette transporter, selectively modulates the biological potency of steroid hormones. Proc. Natl. Acad. Sci. (USA) 92, 4701-4705.
31. Kralli, A., and Yamamoto, K.R. (1996). An FK506-sensitive transporter selectively decreases intracellular levels and potency of steroid hormones. J. Biol. Chem. 271, 17152-17156.
32. Kuchler, K., Dohlman, H., and Thorner, J. (1993). The a-factor transporter (STE6 gene product) and cell polarity in Saccharomyces cerevisiae. J. Cell Biol. 220, 1203-1215.
33. Kuchler, K., and Egner, R. (1997). Unusual protein secretion and translocation pathways in yeast: implication of ABC transporters. In: Unusual Secretory Pathways: From Bacteria to Man, eds. A. Rubartelli, K. Kuchler, and B. Holland: Landes Bioscience Publishers, 49-85.
34. Kunz, J., and Hall, M.N. (1993). Cyclosporin A, FK506 and rapamycin: more than just immunosupression. Trends Biochem. Sci. 18, 334-338.
35. Lefstin, J.A., Thomas, J.R., and Yamamoto, K.R. (1994). Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev. 8, 2842-2856.
36. Loo, T.W., and Clarke, D.M. (1993). Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein. J. Biol. Chem. 268, 19965-19972.
37. Loo, T.W., and Clarke, D.M. (1994a). Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein. J. Biol. Chem. 269, 7243-7248.
38. Loo, T.W., and Clarke, D.M. (1994b). Mutations to amino acids located in predicted transmembrane segment 6 (TM6) modulate the activity and substrate specificity of human P-glycoprotein. Biochemistry 33, 14049-14057.
39. Loo, T.W., and Clarke, D.M. (1995a). Covalent modification of human P-glycoprotein mutants containing a single cysteine in either nucleotide-binding fold abolishes drug-stimulated ATPase activity. J. Biol. Chem. 270, 22957-22961.
40. Loo, T.W., and Clarke, D.M. (1995b). Membrane topology of a cysteine-less mutant of human P-glycoprotein. J. Biol. Chem. 270, 843-848.
41. Loo, T.W., and Clarke, D.M. (1996). Inhibition of oxidative crosslinking between engineered cysteine residues at positions 332 in predicted transmembrane segments (TM) 6 and 975 in predicted TM12 of human P-glycoprotein by drug substrates. J. Biol. Chem. 271, 27482-27487.
42. Loo, T.W., and Clarke, D.M. (1997). Correction of defective protein kinesis of human P-glycoprotein mutants by substrates and modulators. J. Biol. Chem. 272, 709-712.
43. Mahé, Y., Lemoine, Y., and Kuchler, K. (1996a). The ATP binding cassette transporters Pdr5 and Snq2 of Saccharomyces cerevisiae can mediate transport of steroids in vivo. J. Biol. Chem. 271, 25167-25172.
44. Mahé, Y., Parle-McDermott, A.G., Nourani, A., Delahodde, A., Lamprecht, A., and Kuchler, K. (1996b). The ATP-binding cassette multidrug transporter Snq2 of Saccharomyces cerevisiae: a novel target for the transcription factors Pdr1 and Pdr3. Mol. Microbiol. 20, 109-117.
45. Mueller, M., Bakos, E., Welker, E., Varadi, A., Germann, U.A., Gottesman, M.M., Morse, B.S., Roninson, LB., and Sarkadi, B. (1996). Altered drug-stimulated ATPase activity in mutants of the human multidrug resistance protein. J. Biol. Chem. 272, 1877-1883.
46. Parle-McDermott, A.G., Hand, N.J., Goulding, S.E., and Wolfe, K.H. (1996). Sequence of 29 kb around the PDR10 locus on the right arm of Saccharomyces cerevisiae chromosome XV: similarity to part of chromosome I. Yeast 22, 999-1004.
47. Pawagi, A.B., Wang, J., Silverman, M., Reithmeier, R.A. F., and Deber, C.M. (1994). Transmembrane aromatic amino acid distribution in P-glycoprotein: a functional role in broad substrate specificity. J. Mol. Biol. 235, 554-564.
48. Prasad, R., Dewergifosse, P., Goffeau, A., and Balzi, E. (1995). Molecular cloning and characterization of a novel gene of Candida albicans, Cdr1, conferring multiple resistance to drugs and antifungals. Curr. Genet. 27, 320-329.
49. Rao, U.S., and Scarborough, G.A. (1994). Direct demonstration of high affinity interactions of immunosuppressant drugs with the drug binding site of the human P-glycoprotein. Mol. Pharmacol. 45, 773-776.
50. Rose, M.D., and Fink, G.R. (1987). KAR1, a gene required for function of both intranuclear and extranuclear microtubules in yeast. Cell 48 1047-1060.
51. Rose, M.D., Winston, F., and Mieter, P. (1990). Methods in Yeast Genetics. A Laboratory Course Manual, Plainview, NY: Gold Spring Harbor Laboratory Press.
52. Rosenberg, M.F., Callaghan, R., Ford, R.C., and Higgins, C. (1997). Structure of the multidrug resistance P-glycoprotein to 2.5 nm resolution determined by electron microscopy and image analysis. J. Biol. Chem. 272, 10685-10694.
53. Rost, B., and Sander, C. (1994). Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 29, 55-77.
54. Rost, B., and Sander, C. (1993). Prediction of protein secondary structure at better than 70% accuracy. J. Mol. Biol. 232, 584-599.
55. Sanger, F., Nicklen, G.G., and Coulson, A.R. (1977). DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. (USA) 74, 5463-5467.
56. Sanglard, D., Ischer, F., Monod, M., and Bille, J. (1997). Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. Microbiology 143, 405-416.
57. Sanglard, D., Ischer, F., Monod, M., and Bille, J. (1996). Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors. Antimicrob. Agents Chemother. 40, 2300-2305.
58. Sanglard, D., Kuchler, K., Ischer, F., Pagani, J.L., Monod, M., and Bille, J. (1995). Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters. Antimicrob. Agents Chemother. 39, 2378-2386.
59. Servos, J., Haase, E., and Brendel, M. (1993). Gene SNQ2 of Saccharomyces cerevisiae, which confers resistance to 4-nitroquinoline-Noxide and other chemicals, encodes a 169 kDa protein homologous to ATP-dependent permeases. Mol. Gen. Genet. 236, 214-218.
60. Sikorski, R.S., and Hieter, P. (1989). A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 322, 19-27.
61. Ueda, K., Cardarelli, C., Gottesman, M.M., and Pastan, I. (1987). Expression of a full-length cDNA for the human MDRl gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc. Natl. Acad. Sci. (USA) 54, 3004-3008.
62. Van der Bliek, A.M., Baas, F., Ten, H. d.L. T., Kooiman P.M., Van, d.V. K.T., and Borst, P. (1987). The human mdr3 gene encodes a novel P-glycoprotein homologue and gives rise to alternatively spliced mRNAs in liver. EMBO J. 6, 3325-3331.
63. van Helvoort, A., Smith, A. J., Sprong, H., Fritzsche, I., Schinkel, A. H., Borst, P., and van Meer, G. (1996). MDRl P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87, 507-517.
64. Ward, C.L., Omura, S., and Kopito, R.R. (1995). Degradation of CFTR by the ubiquitin-proteasome pathway. Cell 83, 121-127.
65. Zaman, G.J., Flens, M.J., van Leusden, M.R., de Haas, M., Mulder, H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J., and Borst, P. (1994). The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. (USA) 91, 8822-8826.
66. Zhang, X., Collins, K.I., and Greenberger, L.M. (1995). Functional evidence that transmembrane 12 and the loop between transmembrane 11 and 12 form part of the drug-binding domain in P-glycoprotein encoded by MDRl. J. Biol. Chem. 270, 5441-5448.
67. Zhifeng, C., Hirata, D., Tsuchiya, E., Osada, H., and Miyakawa, T. (1996). The multidrug resistance-associated protein (MRP) subramiliy (Yrs1/Yor1) of Saccharomyces cerevisiae is important for the tolerance to a broad range of organic anions. J. Biol. Chem. 272, 14712-14716.
68. Zinser, E., Sperka-Gottlieb, C.D. M., Fasch, E., Kohlwein, F.F., and Daum, G. (1991). Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote Saccharomyces cerevisiae. J. Bacteriol. 173, 2026-2034.